[{"address1": "99 High Street", "address2": "30th Floor", "city": "Boston", "state": "MA", "zip": "02110", "country": "United States", "phone": "617 300 8460", "website": "https://praxismedicines.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance. The company's platforms include cerebrum, a small molecule platform for CNS small molecule therapies to develop orally available precision therapies; and solidus to discover and develop antisense oligonucleotide. It also develops Ulixacaltamide, a small molecule inhibitor of T-type calcium channels that is in Phase 3 clinical trial for the treatment of essential tremor; Vormatrigine, a small molecule targeting the hyperexcitable state of sodium-channels in the brain to treat focal onset epilepsy; Relutrigine for the treatment of developmental and epileptic encephalopathies; PRAX-020 to treat KCNT1; and PRAX-050. In addition, the company develops Elsunersen, a clinical-stage ASO designed to regulate NaV1.2 expression for the treatment of SCN2A-DEE; PRAX-080 that targets PCDH19-related developmental epilepsy; PRAX-090 for targeting SYNGAP1 loss-of-function; and PRAX-100 that targets SCN2A LoF mutations. It has a license agreement with RogCon Inc.; and research collaboration and license agreement with Ionis Pharmaceuticals, Inc. Praxis Precision Medicines, Inc. was incorporated in 2015 and is based in Boston, Massachusetts.", "fullTimeEmployees": 116, "companyOfficers": [{"maxAge": 1, "name": "Mr. Marcio Silva De'Souza M.B.A.", "age": 45, "title": "President, CEO & Director", "yearBorn": 1979, "fiscalYear": 2024, "totalPay": 1635958, "exercisedValue": 0, "unexercisedValue": 3699450}, {"maxAge": 1, "name": "Mr. Timothy Edwin Kelly", "age": 51, "title": "CFO & Treasurer", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 943077, "exercisedValue": 0, "unexercisedValue": 1056212}, {"maxAge": 1, "name": "Mr. Alex  Nemiroff J.D.", "age": 45, "title": "General Counsel & Secretary", "yearBorn": 1979, "fiscalYear": 2024, "totalPay": 816300, "exercisedValue": 0, "unexercisedValue": 860184}, {"maxAge": 1, "name": "Dr. Steven  Petrou B.Sc. (Hons.), Ph.D.", "title": "Co-Founder & Chief Scientific Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Lauren  Mastrocola", "title": "VP of Finance & Principal Accounting Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Karl  Hansen Ph.D.", "title": "Chief Technical Operations Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kelly  McCue", "title": "Chief People Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Alyssa J. S. Wyant", "age": 49, "title": "Chief Regulatory & Quality Officer", "yearBorn": 1975, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Megan T. Sniecinski", "age": 42, "title": "Chief Business Officer", "yearBorn": 1982, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brian  Spar", "title": "Chief of Staff", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 8, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 10, "governanceEpochDate": 1764547200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 189.97, "open": 241.0, "dayLow": 240.41, "dayHigh": 277.14, "regularMarketPreviousClose": 189.97, "regularMarketOpen": 241.0, "regularMarketDayLow": 240.41, "regularMarketDayHigh": 277.14, "payoutRatio": 0.0, "beta": 2.975, "forwardPE": -22.730524, "volume": 2883706, "regularMarketVolume": 2883706, "averageVolume": 1005403, "averageVolume10days": 1254190, "averageDailyVolume10Day": 1254190, "bid": 141.25, "ask": 234.63, "bidSize": 2, "askSize": 2, "marketCap": 6201528832, "fiftyTwoWeekLow": 26.7, "fiftyTwoWeekHigh": 277.44, "allTimeHigh": 914.265, "allTimeLow": 11.85, "priceToSalesTrailing12Months": 830.97, "fiftyDayAverage": 147.8852, "twoHundredDayAverage": 69.344826, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 5934807552, "profitMargins": 0.0, "floatShares": 20522135, "sharesOutstanding": 25007171, "sharesShort": 3613141, "sharesShortPriorMonth": 2611630, "sharesShortPreviousMonthDate": 1760486400, "dateShortInterest": 1763078400, "sharesPercentSharesOut": 0.1445, "heldPercentInsiders": 0.00182, "heldPercentInstitutions": 0.96019, "shortRatio": 2.49, "shortPercentOfFloat": 0.1447, "impliedSharesOutstanding": 25007171, "bookValue": 16.229, "priceToBook": 15.280671, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -273036000, "trailingEps": -12.97, "forwardEps": -10.91, "lastSplitFactor": "1:15", "lastSplitDate": 1701216000, "enterpriseToRevenue": 795.231, "enterpriseToEbitda": -20.259, "52WeekChange": 2.7258112, "SandP52WeekChange": 0.13506866, "quoteType": "EQUITY", "currentPrice": 247.99, "targetHighPrice": 540.0, "targetLowPrice": 77.0, "targetMeanPrice": 331.6, "targetMedianPrice": 330.0, "recommendationMean": 1.4, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 15, "totalCash": 267156992, "totalCashPerShare": 10.683, "ebitda": -292951008, "totalDebt": 436000, "quickRatio": 5.052, "currentRatio": 5.178, "totalRevenue": 7463000, "debtToEquity": 0.127, "revenuePerShare": 0.353, "returnOnAssets": -0.45086, "returnOnEquity": -0.75198996, "grossProfits": -238434000, "freeCashflow": -133374752, "operatingCashflow": -228864992, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -39.27509, "financialCurrency": "USD", "symbol": "PRAX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1764982760, "regularMarketTime": 1764968400, "marketState": "CLOSED", "priceEpsCurrentYear": -18.913021, "fiftyDayAverageChange": 100.10481, "fiftyDayAverageChangePercent": 0.67690897, "twoHundredDayAverageChange": 178.64517, "twoHundredDayAverageChangePercent": 2.576186, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-10-16", "averageAnalystRating": "1.4 - Strong Buy", "cryptoTradeable": false, "exchange": "NMS", "messageBoardId": "finmb_409236524", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1602855000000, "postMarketChangePercent": 1.6169984, "postMarketPrice": 252.0, "postMarketChange": 4.0099945, "regularMarketChange": 58.02, "regularMarketDayRange": "240.41 - 277.14", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1005403, "fiftyTwoWeekLowChange": 221.29001, "fiftyTwoWeekLowChangePercent": 8.288015, "fiftyTwoWeekRange": "26.7 - 277.44", "fiftyTwoWeekHighChange": -29.449997, "fiftyTwoWeekHighChangePercent": -0.10614906, "fiftyTwoWeekChangePercent": 272.58112, "earningsTimestamp": 1762349400, "earningsTimestampStart": 1762349400, "earningsTimestampEnd": 1762349400, "earningsCallTimestampStart": 1754310600, "earningsCallTimestampEnd": 1754310600, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -12.97, "epsForward": -10.91, "epsCurrentYear": -13.11213, "shortName": "Praxis Precision Medicines, Inc", "longName": "Praxis Precision Medicines, Inc.", "regularMarketChangePercent": 30.5417, "regularMarketPrice": 247.99, "displayName": "Praxis Precision Medicines", "trailingPegRatio": null, "__fetch_time": "2025-12-06"}]